相关实验视频

Updated: Sep 11, 2025

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

克里斯普尔-Cas9单核酸编辑结核性硬化综合体2基因在介质细胞干细胞中

Abdallah Salemdawod^1,2, Brandon Cooper³, Yajie Liang¹

¹Department of Diagnostic Radiology and Nuclear Medicine, Program in Image-Guided Neurointerventions, University of Maryland Baltimore, Baltimore, Maryland, USA.

The CRISPR journal

|August 14, 2025

概括

这项研究表明,有效的CRISPR-Cas9基因编辑可诱导人类介质干细胞 (hMSCs) 中特定的结核硬化综合体2 (TSC2) 突变. 这种方法允许精确的基因改造,有助于癌症研究.

科学领域:

遗传学遗传学是一个
分子生物学分子生物学
癌症研究癌症研究

背景情况:

结核性硬化综合体2 (TSC2) 基因调节mTOR通路,对于细胞生长至关重要.
功能丧失的TSC2突变驱动瘤的发展,并且与乳腺癌等癌症的不良预后有关.
点突变是数据库中发现的最常见的TSC2突变.

研究的目的:

评估诱导介质干细胞 (MSC) 中特定TSC2点突变的可行性.
评估CRISPR-Cas9传递方法用于针对性TSC2突变诱导.
建立一种方法来研究TSC2突变在原始细胞中的影响.

主要方法:

使用了CRISPR-Cas9基因编辑技术.
针对三种常见的TSC2点突变:c.1864 C>T (p.Arg622Trp),c.1832 G>A (p.Arg611Glu) 和c.5024 C>T (p.Pro1675Leu). 这些突变的目标是:
在人类MSC (hMSCs) 中采用了基于脂胺的转染和CRISPR-Cas9的另一种传递方法.

主要成果:

获得高编辑效率,高达85%,用于诱导hMSC中的TSC2点突变.
基于脂质胺的转染证明是有效的交付CRISPR-Cas9组件.
在初级hMSCs中成功诱导特定的TSC2突变.

结论:

在使用CRISPR-Cas9.9的初级hMSC中,可以实现TSC2突变的高编辑效率.
这种技术可以在没有细胞系衍生的情况下诱导和潜在逆转突变.
促进研究TSC2相关的癌症和mTOR通路在初级细胞模型.

更多相关视频

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...